Amplify Energy Corp. Common Stock (AMPY)
5.3400
+0.1400 (2.69%)
Amplify Energy Corp is an independent oil and natural gas company focused on the exploration, production, and development of energy resources in the United States
The company specializes in acquiring and managing assets in oil-rich regions, primarily operating in mature basins where it employs advanced technologies and innovative techniques to enhance production and maximize recovery. Amplify Energy is committed to sustainable practices and aims to generate value for its shareholders while minimizing environmental impact. Through strategic investments and operational efficiencies, the company works to optimize its portfolio of upstream energy assets.
![](https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/stock_down_resized_901c19c371.jpg)
Amplify Energy will issue approximately 26.7 million shares of its common stock to Juniper and assume roughly $133 million in net debt.
Via Stocktwits · January 15, 2025
![](https://cdn.benzinga.com/files/images/story/2025/01/15/handshake-merger.jpeg?width=1200&height=800&fit=crop)
Amplify Energy's stock drops following the announcement of a merger with Juniper Capital, set to close in Q2 2025.
Via Benzinga · January 15, 2025
![](https://talkmarkets.com/images/logos/talkmarkets.png)
Amplify Energy Corp. is an independent oil and natural gas company, which engages in the acquisition, development, exploration, and production of oil and natural gas properties.
Via Talk Markets · July 24, 2024
![](https://investorplace.com/wp-content/uploads/2022/08/microcapstocks1600.png)
Investors should know the risks of micro-cap stocks before looking into these three high-potential companies with low prices.
Via InvestorPlace · July 8, 2024
![](https://investorplace.com/wp-content/uploads/2019/07/cheap-bargain-word.jpg)
While you typically get what you pay for, these cheap stocks under $10 prove that occasionally, you can find some true gems.
Via InvestorPlace · July 4, 2024
![](https://investorplace.com/wp-content/uploads/2022/05/earnings-season-1600.png)
AMPY stock results show that Amplify Energy missed analyst estimates for earnings per share but beat on revenue for the first quarter of 2024.
Via InvestorPlace · May 8, 2024
![](https://cdn.benzinga.com/files/images/story/2023/earnings_image.jpeg?width=1200&height=800&fit=crop)
Companies Reporting Before The Bell • Kosmos Energy (NYSEKOS) is expected to report quarterly earnings at $0.16 per share on revenue of $366.82 million.
Via Benzinga · November 6, 2023
![](/next-assets/images/schema-image-default.png)
Via Benzinga · May 12, 2023
![](https://investorplace.com/wp-content/uploads/2023/04/oil-stocks1600.png)
Penny oil stocks are a strong choice as crude prices continue their upward movement thanks to global turmoil.
Via InvestorPlace · April 29, 2024
![](https://investorplace.com/wp-content/uploads/2022/05/earnings-season-1600.png)
AMPY stock results show that Amplify Energy beat analyst estimates for earnings per share and beat on revenue for the fourth quarter of 2023.
Via InvestorPlace · March 6, 2024
![](https://investorplace.com/wp-content/uploads/2021/09/undervalued-stocks.jpg)
rWith September typically a bad month for stocks, investors may want to keep an eye on these undervalued safe stocks.
Via InvestorPlace · September 13, 2023
![](https://cdn.benzinga.com/files/images/story/2023/earnings_image.jpeg?width=1200&height=800&fit=crop)
Companies Reporting Before The Bell • CTS (NYSECTS) is estimated to report quarterly earnings at $0.14 per share on revenue of $708.85 million.
Via Benzinga · March 6, 2024
![](https://cdn.benzinga.com/files/images/story/2023/03/01/image44.jpg?width=1200&height=800&fit=crop)
U.S. stocks traded lower toward the end of trading, with the Nasdaq Composite dropping around 75 points on Wednesday. The Dow traded down 0.19% to 32,596.21 while the NASDAQ fell 0.66% to 11,379. The S&P 500 also fell, dropping, 0.52% to 3,949.43.
Via Benzinga · March 1, 2023
![](https://cdn.benzinga.com/files/images/story/2023/03/01/image14.jpg?width=1200&height=800&fit=crop)
Gainers Reata Pharmaceuticals Inc (NASDAQRETA) shares jumped 171.5% to $84.67 after the company reported the FDA approval of SKYCLARYS for patients with Friedreich's Ataxia.
Via Benzinga · March 1, 2023
![](https://cdn.benzinga.com/files/images/story/2023/03/01/image_2.jpg?width=1200&height=800&fit=crop)
U.S. stocks traded mixed midway through trading, with the Dow Jones gaining around 30 points on Wednesday. The Dow traded up 0.12% to 32,695.97 while the NASDAQ fell 0.23% to 11,429.16. The S&P 500 also fell, dropping, 0.17% to 3,963.32.
Via Benzinga · March 1, 2023
![](https://cdn.benzinga.com/files/images/story/2023/03/01/image_6_0.jpg?width=1200&height=800&fit=crop)
U.S. stocks traded lower, with the Dow Jones dropping around 80 points on Wednesday. Here are some big stocks recording gains in today’s session.
Via Benzinga · March 1, 2023
![](https://cdn.benzinga.com/files/images/story/2022/12/31/wall_street_bull_shutter.jpg?width=1200&height=800&fit=crop)
2022 would go down as one of the worst years for the financial markets. The sell-off has been all-pervasive, with stocks, bonds and cryptos all selling off indiscriminately. Even as high-fliers like Apple Inc.
Via Benzinga · December 31, 2022
![](https://cdn.benzinga.com/files/images/story/2022/10/31/image30.jpeg?width=1200&height=800&fit=crop)
Wall Street analysts make new stock picks on a daily basis. Unfortunately for investors, not all analysts have particularly impressive track records at predicting market movements. Even when it comes to one single stock, analyst ratings and price targets can vary widely, leaving investors confused about which analyst's opinion to trust.
Via Benzinga · October 31, 2022